Amylyx Pharmaceuticals, Inc.·4

Feb 4, 4:05 PM ET

Mazzariello Gina 4

4 · Amylyx Pharmaceuticals, Inc. · Filed Feb 4, 2026

Research Summary

AI-generated summary of this filing

Updated

Amylyx (AMLX) Chief Legal Officer Gina Mazzariello Sells 3,448 Shares

What Happened
Gina Mazzariello, Chief Legal Officer of Amylyx Pharmaceuticals (AMLX), sold 3,448 shares in an open-market/private sale on February 2, 2026, for a total reported value of $50,516. The reported weighted-average price was $14.65 per share (sales ranged from $14.470 to $14.810). This was a sale to satisfy tax-withholding obligations tied to the vesting of restricted stock units, and the sales were automatic rather than at her discretion.

Key Details

  • Transaction date: 2026-02-02; Form 4 filed: 2026-02-04 (timely within the 2-business-day window).
  • Shares sold: 3,448; weighted-average price: $14.65; total proceeds: $50,516.
  • Price range across multiple trades: $14.470 to $14.810 (weighted average per footnote).
  • Reason/footnote: Sale was automatic to cover tax withholding on RSU vesting (footnote F1).
  • Shares owned after the transaction: not disclosed in the provided filing excerpt.
  • No 10b5-1 plan or other trading instruction was indicated in the disclosed excerpts.

Context
Sales to cover tax withholding on vested awards are routine and generally administrative (not necessarily a signal of insider sentiment). For retail investors, purchases or substantial discretionary sales tend to be more informative than automatic withholding sales.

Insider Transaction Report

Form 4
Period: 2026-02-02
Mazzariello Gina
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-02-02$14.65/sh3,448$50,516144,693 total
Footnotes (2)
  • [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.470 to $14.810. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Signature
/s/ Joshua B. Cohen, as Attorney in Fact|2026-02-04

Documents

1 file
  • 4
    ownership.xmlPrimary

    4